Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata

A systematic review

John Bissler, John C. Kingswood

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Renal angiomyolipomata associated with tuberous sclerosis complex are often bilateral, multiple and progressive. They cause significant morbidity and mortality in older children and adults. Surveillance and pre-emptive treatment reduce this risk. Recent research suggests treatment with mammalian target of rapamycin inhibitors is better at preventing bleeding, recurrence, and preserving renal function than percutaneous embolization.

Original languageEnglish (US)
Pages (from-to)279-290
Number of pages12
JournalTherapeutic Advances in Urology
Volume8
Issue number4
DOIs
StatePublished - Aug 1 2016

Fingerprint

Angiomyolipoma
Tuberous Sclerosis
Kidney
Sirolimus
Hemorrhage
Morbidity
Recurrence
Mortality
Therapeutics
Research

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata : A systematic review. / Bissler, John; Kingswood, John C.

In: Therapeutic Advances in Urology, Vol. 8, No. 4, 01.08.2016, p. 279-290.

Research output: Contribution to journalReview article

@article{2ab150f8fbf04b549c5f2165a38c0d7e,
title = "Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: A systematic review",
abstract = "Renal angiomyolipomata associated with tuberous sclerosis complex are often bilateral, multiple and progressive. They cause significant morbidity and mortality in older children and adults. Surveillance and pre-emptive treatment reduce this risk. Recent research suggests treatment with mammalian target of rapamycin inhibitors is better at preventing bleeding, recurrence, and preserving renal function than percutaneous embolization.",
author = "John Bissler and Kingswood, {John C.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1177/1756287216641353",
language = "English (US)",
volume = "8",
pages = "279--290",
journal = "Therapeutic Advances in Urology",
issn = "1756-2872",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata

T2 - A systematic review

AU - Bissler, John

AU - Kingswood, John C.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Renal angiomyolipomata associated with tuberous sclerosis complex are often bilateral, multiple and progressive. They cause significant morbidity and mortality in older children and adults. Surveillance and pre-emptive treatment reduce this risk. Recent research suggests treatment with mammalian target of rapamycin inhibitors is better at preventing bleeding, recurrence, and preserving renal function than percutaneous embolization.

AB - Renal angiomyolipomata associated with tuberous sclerosis complex are often bilateral, multiple and progressive. They cause significant morbidity and mortality in older children and adults. Surveillance and pre-emptive treatment reduce this risk. Recent research suggests treatment with mammalian target of rapamycin inhibitors is better at preventing bleeding, recurrence, and preserving renal function than percutaneous embolization.

UR - http://www.scopus.com/inward/record.url?scp=84978976733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978976733&partnerID=8YFLogxK

U2 - 10.1177/1756287216641353

DO - 10.1177/1756287216641353

M3 - Review article

VL - 8

SP - 279

EP - 290

JO - Therapeutic Advances in Urology

JF - Therapeutic Advances in Urology

SN - 1756-2872

IS - 4

ER -